Skip to main content
CardioComm Solutions, Inc. logo

CardioComm Solutions, Inc. — Investor Relations & Filings

Ticker · EKG ISIN · CA14159N2086 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 130 across all filing types
Latest filing 2025-05-01 Regulatory Filings
Country CA Canada
Listing TSXV EKG

About CardioComm Solutions, Inc.

https://cardiocommsolutions.com/

CardioComm Solutions, Inc. is a global provider of advanced medical electrocardiogram (ECG) and multiple bio-sign monitoring solutions. The company develops ISO 13485 certified, FDA cleared, and Health Canada approved software and hardware for both healthcare professionals and consumers. Core offerings include the GEMS™ software platform for ambulatory cardiac long-term continuous monitoring (LTCM) and the Body-by-GEMS (BBG) system, which acts as a central hub for collecting and analyzing bio-signs (including blood pressure, PO2, and temperature) from various devices and wearables. For the consumer market, CardioComm offers personal ECG monitors like the HeartCheck™ CardiBeat, supported by the GEMS™ mobile app and rapid SMART Monitoring ECG reading services, enabling physician review typically within 30 minutes. CardioComm is recognized as a pioneer in personalized ECG monitoring and Remote Patient Monitoring (RPM) technology.

Recent filings

Filing Released Lang Actions
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is Form 13-501F1 filed with the Alberta Securities Commission to certify participation fee calculations under NI 13-501. It is a regulatory submission form rather than an annual or interim financial report, earnings release, proxy statement, or management presentation. It does not fit any specific category other than a general regulatory filing. Therefore, it is classified as RNS (Regulatory Filings).
2025-05-01 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 1% confidence The document is the Independent Auditor’s Report followed by the audited financial statements (statements of financial position, loss, cash flows, etc.) for CardioComm Solutions, Inc. for the years ended December 31, 2024 and 2023. It is not merely an announcement or summary but contains the full audit opinion and detailed financial statements, fitting the definition of a standalone Audit Report/Information (excluding a full Annual Report with MD&A and broader narrative). Therefore, it should be classified as an AR filing. FY 2024
2025-05-01 English
News release - English.pdf
AGM Information Classification · 1% confidence The document is a press release specifically about the distribution of the Annual General Meeting (“AGM”) materials (information circular, meeting materials) due to a Canada Post strike, including instructions on how shareholders can access and request proxies. This is clearly related to AGM logistics and materials, fitting the AGM Information category. It is not the actual AGM materials or results, nor a financial report, but an update concerning the AGM materials. Therefore, the appropriate classification is AGM Information (AGM-R).
2024-12-05 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 Form 52-109FV2 “Venture Issuer Basic Certificate” signed by the CFO certifying the interim financial report and interim MD&A for the period ending September 30, 2024. It is a regulatory compliance certification rather than the interim report itself. There is no evidence of substantive financial data or narrative analysis; instead, it is a regulatory filing form required by securities legislation. It does not fit any specific category like Interim Report (IR) since it is merely the certification, nor does it match categories for earnings releases, MD&A, or other specialized filings. Therefore, it falls under “Regulatory Filings” as the fallback.
2024-11-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 venture issuer basic certificate certifying the review and fair presentation of interim filings (interim financial report and interim MD&A) for the period ended September 30, 2024. It is not the interim report itself but a regulatory certification form filed under Canadian securities rules. There is no specific classification for certification forms, so this falls under the fallback category for miscellaneous regulatory filings.
2024-11-29 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled "Management's Discussion and Analysis" for the three and nine months ended September 30, 2024 and contains management’s detailed narrative on the company’s financial performance, business trends, and outlook. This aligns precisely with the definition of a Management Report (MD&A). It is not merely an announcement or summary, but the substantive MD&A itself. Therefore, the correct classification is MDA.
2024-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.